Matches in Wikidata for { <http://www.wikidata.org/entity/Q92563116> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q92563116 description "2020 թվականի հունվարի 10-ին հրատարակված գիտական հոդված" @default.
- Q92563116 description "artículu científicu espublizáu en xineru de 2020" @default.
- Q92563116 description "scientific article published on 10 January 2020" @default.
- Q92563116 description "wetenschappelijk artikel" @default.
- Q92563116 description "наукова стаття, опублікована 10 січня 2020" @default.
- Q92563116 name "Phase I Study of Trifluridine/Tipiracil Plus Irinotecan and Bevacizumab in Advanced Gastrointestinal Tumors" @default.
- Q92563116 name "Phase I Study of Trifluridine/Tipiracil Plus Irinotecan and Bevacizumab in Advanced Gastrointestinal Tumors" @default.
- Q92563116 type Item @default.
- Q92563116 label "Phase I Study of Trifluridine/Tipiracil Plus Irinotecan and Bevacizumab in Advanced Gastrointestinal Tumors" @default.
- Q92563116 label "Phase I Study of Trifluridine/Tipiracil Plus Irinotecan and Bevacizumab in Advanced Gastrointestinal Tumors" @default.
- Q92563116 prefLabel "Phase I Study of Trifluridine/Tipiracil Plus Irinotecan and Bevacizumab in Advanced Gastrointestinal Tumors" @default.
- Q92563116 prefLabel "Phase I Study of Trifluridine/Tipiracil Plus Irinotecan and Bevacizumab in Advanced Gastrointestinal Tumors" @default.
- Q92563116 P1433 Q92563116-A0526496-E132-4F9F-AB19-642677FDA916 @default.
- Q92563116 P1476 Q92563116-F2C1A30A-9E75-4424-9681-A121703973AE @default.
- Q92563116 P2093 Q92563116-69A9D736-E7CB-4E86-969D-4AC6F7225021 @default.
- Q92563116 P2093 Q92563116-7EBDD821-DB91-4195-85FA-F5497FC97FEC @default.
- Q92563116 P2093 Q92563116-84D04730-507D-48B2-AD95-B89346FE324E @default.
- Q92563116 P2093 Q92563116-A98A98F1-DA95-4606-A87A-102645820841 @default.
- Q92563116 P2093 Q92563116-BB7B17CE-8D61-4321-9F2F-C9A53F84EAC8 @default.
- Q92563116 P304 Q92563116-42C46863-5679-4B47-AB91-147F3FAB6807 @default.
- Q92563116 P31 Q92563116-D71BD7CC-1502-4BF9-B891-AF4C181F71EA @default.
- Q92563116 P356 Q92563116-93ABD5C1-AC7E-4863-A6FC-472B8D3F56A1 @default.
- Q92563116 P433 Q92563116-08EC7AF5-DE0F-4A69-BB1B-4FE2825FBE45 @default.
- Q92563116 P478 Q92563116-23AF5FCE-8959-47DF-A6A5-89E9E0274998 @default.
- Q92563116 P50 Q92563116-0B483B95-4CD5-4740-9097-2C4F319CDE43 @default.
- Q92563116 P50 Q92563116-1FE8D8F1-48FE-453A-BACA-12D4EA318303 @default.
- Q92563116 P50 Q92563116-56127969-E314-46EE-A4D4-4392FA8BAF89 @default.
- Q92563116 P50 Q92563116-8106FB29-7385-42BA-833F-4BD3E0CB2093 @default.
- Q92563116 P577 Q92563116-20B52FD0-D3DB-4857-95CF-00FA1C6E6E08 @default.
- Q92563116 P698 Q92563116-1AD05D9A-D12F-4EA8-87FA-A0FB764D5C61 @default.
- Q92563116 P921 Q92563116-02F222C5-9166-4588-8C73-DC737531E8FC @default.
- Q92563116 P921 Q92563116-7529FFA5-55C5-4040-9BB7-E0B345DD87E8 @default.
- Q92563116 P356 1078-0432.CCR-19-2743 @default.
- Q92563116 P698 31924737 @default.
- Q92563116 P1433 Q332253 @default.
- Q92563116 P1476 "Phase I Study of Trifluridine/Tipiracil Plus Irinotecan and Bevacizumab in Advanced Gastrointestinal Tumors" @default.
- Q92563116 P2093 "Al B Benson" @default.
- Q92563116 P2093 "Anna M Varghese" @default.
- Q92563116 P2093 "Dana B Cardin" @default.
- Q92563116 P2093 "Kensuke Hamada" @default.
- Q92563116 P2093 "Lukas Makris" @default.
- Q92563116 P304 "1555-1562" @default.
- Q92563116 P31 Q13442814 @default.
- Q92563116 P356 "10.1158/1078-0432.CCR-19-2743" @default.
- Q92563116 P433 "7" @default.
- Q92563116 P478 "26" @default.
- Q92563116 P50 Q37830465 @default.
- Q92563116 P50 Q91134026 @default.
- Q92563116 P50 Q92563104 @default.
- Q92563116 P50 Q92563107 @default.
- Q92563116 P577 "2020-01-10T00:00:00Z" @default.
- Q92563116 P698 "31924737" @default.
- Q92563116 P921 Q412197 @default.
- Q92563116 P921 Q413299 @default.